A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Bone & Soft Tissue Cancer (Sarcoma) Bookmark and Share

Pediatric Musculoskeletal Cancer and Sarcoma Program

Every day, City of Hope treats patients of all ages – children, adolescents and adults – who are referred to us by physicians from California and throughout the U.S.
 
Children with musculoskeletal cancers find more than hope here. They and their families find expedited diagnosis and rapid treatment that begins in hours or days, not weeks. Because musculoskeletal cancers can be especially aggressive and fast-growing, our team of specialists and clinicians collaborate efficiently on the best course of treatment for each patient.
 
Treatment for these bone and soft tissue cancers combines chemotherapy and other drugs with surgery and radiation. City of Hope researchers pioneered the use of hematopoietic cell transplantation (HCT) as a treatment option for patients with advanced sarcoma, and a current study involves the use of new imaging techniques, novel radiation oncology techniques and HCT. Our approach integrates powerful new anti-cancer drugs with alternative therapies in an effort to spare patients’ limbs. We are successful in this effort in 85 percent of our cases.

We are one of the few centers in the nation that perform limb-sparing reconstruction using expandable prosthetic implants for children and adolescents. These prostheses “grow” with patients as they are expanded using noninvasive or minimally invasive techniques. This allows us to accommodate for your child’s continued growth without multiple major surgeries. Using these devices, we are able to remove bone cancer and save limbs, while at the same time reducing the number of surgeries and improving recovery time.
 
As part of the Pediatric Musculoskeletal Cancer and Sarcoma Program, care is provided by a multidisciplinary team of surgical oncologists, medical oncologists and radiation oncologists who work together with pathologists, radiologists, rehabilitation experts and others to achieve the best possible outcomes for patients. To help patients and families adjust during treatment and rehabilitation, psychologists, psychiatrists, social workers and child life specialists provide psychosocial support. Our team includes:

Judith K. Sato, M.D., director
George T. Calvert, M.D.
Dominic Femino, M.D.
James S. Miser, M.D.
Helen Mormann, F.N.P.
Margarita Munoz, PA-C
Amy Tafel, M.S.W.

A unique benefit of being treated at City of Hope is that we treat patients of all ages in our musculoskeletal program. If your child relapses or requires continued treatment or follow-up into adulthood, your family can stay with a team you know and trust, providing greater continuity of care.

As one of a handful of institutes to attain the elite designation of  Comprehensive Cancer Center by the National Cancer Institute (NCI), City of Hope is acknowledged as a leader in cancer research and treatment. Here, your child has access to innovative clinical trials, researchers and physicians who are nationally recognized experts in developing novel methods for preventing, detecting and treating soft tissue sarcoma and bone cancer. We are actively developing tomorrow’s treatments today, and our musculoskeletal investigators are collaborating with other scientists in other disciplines to develop promising new treatments.
 
For more information about our musculoskeletal treatments and research, visit our Musculoskeletal Cancer and Sarcoma Program website.
 

Bone & Soft Tissue Cancer (Sarcoma)

Pediatric Musculoskeletal Cancer and Sarcoma Program

Every day, City of Hope treats patients of all ages – children, adolescents and adults – who are referred to us by physicians from California and throughout the U.S.
 
Children with musculoskeletal cancers find more than hope here. They and their families find expedited diagnosis and rapid treatment that begins in hours or days, not weeks. Because musculoskeletal cancers can be especially aggressive and fast-growing, our team of specialists and clinicians collaborate efficiently on the best course of treatment for each patient.
 
Treatment for these bone and soft tissue cancers combines chemotherapy and other drugs with surgery and radiation. City of Hope researchers pioneered the use of hematopoietic cell transplantation (HCT) as a treatment option for patients with advanced sarcoma, and a current study involves the use of new imaging techniques, novel radiation oncology techniques and HCT. Our approach integrates powerful new anti-cancer drugs with alternative therapies in an effort to spare patients’ limbs. We are successful in this effort in 85 percent of our cases.

We are one of the few centers in the nation that perform limb-sparing reconstruction using expandable prosthetic implants for children and adolescents. These prostheses “grow” with patients as they are expanded using noninvasive or minimally invasive techniques. This allows us to accommodate for your child’s continued growth without multiple major surgeries. Using these devices, we are able to remove bone cancer and save limbs, while at the same time reducing the number of surgeries and improving recovery time.
 
As part of the Pediatric Musculoskeletal Cancer and Sarcoma Program, care is provided by a multidisciplinary team of surgical oncologists, medical oncologists and radiation oncologists who work together with pathologists, radiologists, rehabilitation experts and others to achieve the best possible outcomes for patients. To help patients and families adjust during treatment and rehabilitation, psychologists, psychiatrists, social workers and child life specialists provide psychosocial support. Our team includes:

Judith K. Sato, M.D., director
George T. Calvert, M.D.
Dominic Femino, M.D.
James S. Miser, M.D.
Helen Mormann, F.N.P.
Margarita Munoz, PA-C
Amy Tafel, M.S.W.

A unique benefit of being treated at City of Hope is that we treat patients of all ages in our musculoskeletal program. If your child relapses or requires continued treatment or follow-up into adulthood, your family can stay with a team you know and trust, providing greater continuity of care.

As one of a handful of institutes to attain the elite designation of  Comprehensive Cancer Center by the National Cancer Institute (NCI), City of Hope is acknowledged as a leader in cancer research and treatment. Here, your child has access to innovative clinical trials, researchers and physicians who are nationally recognized experts in developing novel methods for preventing, detecting and treating soft tissue sarcoma and bone cancer. We are actively developing tomorrow’s treatments today, and our musculoskeletal investigators are collaborating with other scientists in other disciplines to develop promising new treatments.
 
For more information about our musculoskeletal treatments and research, visit our Musculoskeletal Cancer and Sarcoma Program website.
 
Patient Care Overview

City of Hope Locations

Cancer Care
For the 11th year, U.S.News & World Report has named City of Hope one of the top cancer hospitals in the country.
NEWS & UPDATES
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...
  • Cancer treatment can take a toll on the mouth, even if a patient’s cancer has nothing to do with the head or throat, leading to a dry mouth, or a very sore mouth, and making it difficult to swallow or eat. Here’s some advice from the National Cancer Institute (NCI)  on how to ease cancer-related dis...
  • Radiation oncology is one of the three main specialties involved in the successful treatment of cancer, along with surgical oncology and medical oncology. Experts in this field, known as radiation oncologists, advise patients as to whether radiation therapy will be useful for their cancer – and how it can best ...
  • There’s more to cancer care than simply helping patients survive. There’s more to cancer treatment than simple survival. Constant pain should not be part of conquering cancer,  insists Betty Ferrell, Ph.D., R.N., director of nursing research and education at City of Hope. She wants patients and caregivers...
  • Even its name is daunting. Systemic mastocytosis is a fatal disease of the blood with no known cure. But a new study suggests a bone marrow transplant may be the answer for some patients. While rare, systemic mastocytosis is resistant to treatment with drugs and, when aggressive, can be fatal within four years ...
  • Could what you eat affect the health of your chromosomes? The short answer is, “Yes.” Researchers led by Dustin Schones, Ph.D., assistant professor in the Department of Cancer Biology, and Rama Natarajan, Ph.D., director of the Division of Molecular Diabetes Research and the National Business Products Industry ...
  • September is Prostate Cancer Awareness Month. Here, Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope, explains the importance of understanding the risk factors for the disease and ways to reduce those risks, as well as overall prostate health. “Wha...
  • ** Learn more about prostate health, plus prostate cancer research and treatment, at City of Hope. ** Learn more about getting a second opinion at City of Hope by visiting us online or by calling 800-826-HOPE (4673). City of Hope staff will explain what’s required for a consult at City of Hope and help yo...
  • Childhood cancer survival rates have increased dramatically over the past 40 years. More than 80 percent of children with cancer now survive five years or more, which is a tremendous feat. Despite the survival rate increase, cancer continues to be the No. 1 disease killer and second-leading cause of death in ch...